Skip to main content

GOLDMAN SACHS GROUP INC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in TRVI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$14,647,319
+$1,415,045 QoQ
Shares Held
1,227,772
+16.2% QoQ
Ownership
0.865%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 99.98696826446604.ToString("F0")% Shared 0.ToString("F0")% None 0.013031735533959072.ToString("F0")%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. TRVI ranks #121 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,647,319 1,227,772
2025-12-31 $13,232,274 1,056,891
2025-09-30 $7,205,203 787,454
2025-06-30 $1,635,776 299,045
2025-03-31 $1,332,680 211,873
2024-12-31 $972,913 236,144
2024-09-30 $548,554 164,238
2024-06-30 $218,115 73,193
2024-03-31 $131,010 37,974
2023-12-31 $32,046 23,915
2023-09-30 $57,007 26,150
2023-06-30 $83,771 35,051